Does CANAKINUMAB Cause Deafness neurosensory? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Deafness neurosensory have been filed in association with CANAKINUMAB (Ilaris). This represents 0.1% of all adverse event reports for CANAKINUMAB.
9
Reports of Deafness neurosensory with CANAKINUMAB
0.1%
of all CANAKINUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Deafness neurosensory From CANAKINUMAB?
Of the 9 reports, 5 (55.6%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Deafness neurosensory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANAKINUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does CANAKINUMAB Cause?
Pyrexia (1,327)
Inappropriate schedule of drug administration (1,238)
Drug ineffective (1,078)
Inappropriate schedule of product administration (944)
Pain (858)
Condition aggravated (771)
Malaise (684)
Off label use (557)
Arthralgia (555)
Rash (505)
What Other Drugs Cause Deafness neurosensory?
METHOTREXATE (224)
FENTANYL (202)
OXYCODONE (198)
ETANERCEPT (171)
TEPROTUMUMAB-TRBW (171)
TOCILIZUMAB (164)
HYDROXYCHLOROQUINE (162)
SULFASALAZINE (153)
ABATACEPT (149)
CELECOXIB (143)
Which CANAKINUMAB Alternatives Have Lower Deafness neurosensory Risk?
CANAKINUMAB vs CANDESARTAN
CANAKINUMAB vs CANDESARTAN CILEXETIL
CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAKINUMAB vs CANGRELOR
CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN